Last updated on April 2020

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Brief description of study

To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.

Detailed Study Description

The present study comparing the safety and efficacy of 1.25mg/0.05mL Bevacizumab injection via the intracameral route versus the intravitreal route in treating the neovascular glaucoma

Clinical Study Identifier: NCT03648814

Find a site near you

Start Over